Evaluation of Fractalkine and Its Receptor in Peri-implantitis
NCT ID: NCT06685523
Last Updated: 2024-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2024-11-08
2025-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Treatment of Peri-implantitis Defects
NCT06614426
Use of Various Laser Systems in Peri-implatit
NCT04826783
Peri-implant Phenotype, Calprotectin and Mmp-8 Levels in Cases Diagnosed With Peri-implant Disease
NCT06173739
Clinical and Biochemical Evaluation of the Efficacy of Non-Surgical Treatment Approaches in the Treatment of Peri-implantitis
NCT05201443
Effect of Different Non-surgical Treatment Approaches of Peri-implantitis
NCT06730568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
* Peri-implant healty
* Mechanical curette
* Er:YAG laser
* Diyot laser
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group healty
No interventions assigned to this group
Mechanical debridement group
Subgingival debridement
To be applied 1 times (0. days)
Er:YAG laser applied group
Er:YAG laser decontamination
To be applied 3 times
Diyot laser applied group
Diyot laser decontamination
To be applied 3 times
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Subgingival debridement
To be applied 1 times (0. days)
Er:YAG laser decontamination
To be applied 3 times
Diyot laser decontamination
To be applied 3 times
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No systemic disease that may affect the outcome of the treatment
* Patients with healthy periodontium or patients with completed periodontal treatment
* Individuals at least 6 months after prosthesis loading on the implant
* Individuals who do not require further surgery for the treatment of peri-implantitis
* Implants with at least 2 mm keratised gingiva
* Individuals aged 40-60 years
Exclusion Criteria
* Individuals who smoke and drink alcohol
* Individuals in pregnancy or lactation
* Individuals who have received antibiotic treatment in the last three months
* Individuals with parafunctional habits
40 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kubilay BARIŞ
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kubilay BARIŞ
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kırıkkale University, Faculty of Dentistry, Department of Periodontology
Kırıkkale, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KU-DHF-KB-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.